Solana Co — Director's Dealing 2016

Jul 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2016-07-23

Reporting Person: Walter Blane (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-13	Stock Option	$1.07	A	100000	Acquired	2020-07-13	Class A Common Stock (100000)	Direct

Footnotes

F1: Translated into US dollars from Canadian dollars based on buying rate from Federal Reserve Bank. USD $1.00 = CAD $1.2962 on July 13, 2016; based on exercise price of CAD $1.39

F2: 1/3 of total options vested on date of grant; 1/3 will vest on first anniversary of date of grant and 1/3 will vest on second anniversary of date of grant